title: Tamm-Horsfall protein inhibits binding of S- and P-fimbriated Escherichia coli to human renal tubular epithelial cells.
abstract: Escherichia coli is the predominant pathogen in urinary tract infections. Fimbriae are one of the major virulence factors of these bacteria, since these protein appendices contribute towards bacterial adhesion to epithelial cells. In clinical E. coli isolates from urinary tract infections, P fimbriae are more frequently present than S fimbriae. However, these two types of fimbriae mediate adhesion to cultured tubular epithelial cells equally well. Tamm-Horsfall protein, which is the most abundant protein in normal human urine, inhibits hemagglutination by E. coli expressing S fimbriae, but does not interfere with hemagglutination by P-fimbriated E. coli. Therefore, it has been speculated that Tamm-Horsfall protein may serve as a clearance factor for S-fimbriated E. coli in human urine. In our experiments, adherence of purified S fimbriae and of S-fimbriated E. coli to tubular epithelial cells was inhibited by Tamm-Horsfall protein, but the protein also decreased binding of P-fimbriated E. coli to approximately the same degree. We found less adherence of both types of fimbriae to a Madin-Darby canine kidney cell line expressing soluble and membrane-bound Tamm-Horsfall protein as compared with the control cell line. In conclusion, our in vitro data suggest that urinary Tamm-Horsfall protein may serve as a clearance factor for E. coli expressing both S and P fimbriae. In the light of these findings, the low clinical relevance of S-fimbriated E. coli for urinary tract infections may be readily explained; however, the predominance of P fimbriae remains unresolved.
authors.affiliation: Department of Medicine, University of Lubeck, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Leeker
authors.forename: B
authors.initials: B
authors.lastname: Kreft
authors.forename: J
authors.initials: J
authors.lastname: Sandmann
authors.forename: J
authors.initials: J
authors.lastname: Bates
authors.forename: G
authors.initials: G
authors.lastname: Wasenauer
authors.forename: H
authors.initials: H
authors.lastname: Múller
authors.forename: K
authors.initials: K
authors.lastname: Sack
authors.forename: S
authors.initials: S
authors.lastname: Kumar
mesh_terms: D000276:Adjuvants, Immunologic / Q000302:isolation & purification / Q000494:pharmacology*; D000818:Animals; D001422:Bacterial Adhesion / Q000187:drug effects*; D015415:Biomarkers; D002478:Cells, Cultured / Q000187:drug effects / Q000382:microbiology / Q000648:ultrastructure; D004285:Dogs; D004797:Enzyme-Linked Immunosorbent Assay; D004926:Escherichia coli / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D010861:Fimbriae, Bacterial / Q000187:drug effects* / Q000502:physiology; D006388:Hemagglutinins; D006801:Humans; D007150:Immunohistochemistry; D007686:Kidney Tubules, Distal / Q000166:cytology* / Q000382:microbiology; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning; D009088:Mucoproteins / Q000302:isolation & purification / Q000494:pharmacology*; D011817:Rabbits; D014162:Transfection; D058949:Uromodulin
chemical_list: D000276:Adjuvants, Immunologic; D015415:Biomarkers; D006388:Hemagglutinins; D009088:Mucoproteins; C548612:UMOD protein, human; D058949:Uromodulin